Serial Number
79284840
Owner
BAUSCH + LOMB IRELAND LIMITEDAttorney
Nancy L. RoweFiling Date
Mar 16, 2020
XYDRII Trademark
Serial Number: 79284840 • Registration: 6192259
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Nancy L. Rowe Bausch + Lomb
400 Somerset Corp. Blvd.
Law Department
Bridgewater, NJ 08807
United States
Trademark Details
Filing Date
March 16, 2020
Registration Date
November 10, 2020
Published for Opposition
June 30, 2020
Goods & Services
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all of the foregoing excluding pharmaceutical preparations for the treatment or prevention of neurological disorders, sleep disorders, and central nervous system
